Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
NCT03728699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54
Last updated 2023-11-03
Summary
This is a prospective, observational study to collect stool and blood from acute myeloid leukemia patients undergoing intensive chemotherapy.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Sample Collection Blood
Collected from each patient twice weekly.
- DIAGNOSTIC_TEST
-
Stool Sample
Collected from each patient twice weekly.
Sponsors & Collaborators
-
Masonic Cancer Center, University of Minnesota
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-02
- Primary Completion
- 2021-05-17
- Completion
- 2022-02-18
Countries
- United States
Study Locations
More Related Trials
-
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
NCT00898456 ·Status: ACTIVE_NOT_RECRUITING
-
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
NCT00048958 ·Status: ACTIVE_NOT_RECRUITING
-
Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
NCT00002693 ·Status: COMPLETED ·Phase: PHASE1
-
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia
NCT00897182 ·Status: COMPLETED
-
Effectiveness of Protected Environment Rooms for AML and MDS
NCT00443300 ·Status: TERMINATED
-
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
NCT01807091 ·Status: COMPLETED ·Phase: NA
-
Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes
NCT03621241 ·Status: RECRUITING
-
Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
NCT01570465 ·Status: TERMINATED
-
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
NCT01421862 ·Status: UNKNOWN
-
Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML)
NCT00880243 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
NCT00052299 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients
NCT03488862 ·Status: COMPLETED
-
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
NCT00003931 ·Status: COMPLETED
-
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients
NCT04259372 ·Status: COMPLETED
-
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
NCT04293562 ·Status: RECRUITING ·Phase: PHASE3
-
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
NCT03921047 ·Status: RECRUITING
-
Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
NCT00037596 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy
NCT01169363 ·Status: COMPLETED
-
Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia
NCT00003003 ·Status: COMPLETED ·Phase: PHASE1
-
Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .
NCT07343687 ·Status: NOT_YET_RECRUITING
-
Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00499785 ·Status: COMPLETED
-
Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML)
NCT02662920 ·Status: COMPLETED
-
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT00006122 ·Status: COMPLETED ·Phase: PHASE2
-
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
NCT05602168 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients
NCT01929408 ·Status: COMPLETED